EZM0414 Chemical Structure oral SETD2 Inhibitor - Epizyme Inc., Cambridge, MA

oral SETD2 Inhibitor

Ph. I candidate in oncology

in-house library screening and SBDD

ACS Med. Chem. Lett.

Epizyme Inc., Cambridge, MA

Context. EZM0414 (Epizyme, Inc.) is an oral SETD2 inhibitor being developed for hematological malignancies. Although several genetic studies have proposed that the histone methyltransferase SETD2 is a tumor suppressor…

 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.